Montana Cannabis: 107% Capture, a License Freeze, and What Balanced Policy Looks Like

Montana launched adult-use sales January 1, 2022 with 557 dispensaries — 49.2 per 100,000 residents, one of the highest per-capita density of any state studied. Four years later the state captures 107% of resident demand. The surplus isn't a math error. It's 13.8 million annual tourists visiting Glacier and Yellowstone, plus cross-border demand from four neighboring states with no adult-use cannabis. Montana had to freeze new licensing because it was already oversupplied. That's what success looks like.

Market Overview

Montana legalized adult-use cannabis under CI-118 in November 2020. First adult-use sales launched January 1, 2022. The market is regulated by the Montana Department of Revenue.

Key metrics:

• 557 dispensaries across 103 cities and towns
• 2025 combined revenue: $326.9 million ($284.2M adult-use + $42.7M medical; MT Revenue sales reports)
• $5.34/g flower (pre-tax, July 2024–June 2025 average; down from $7.83/g at launch)
• 20–23% total tax burden (20% state excise + 0–3% local option)
• ~107% estimated legal capture
• $587K revenue per store annually
• License moratorium in effect through June 30, 2027

Flower Pricing

Montana's pricing data comes from the Department of Revenue's bi-annual retail price studies. At $5.34/g pre-tax, Montana sits above the mature oversupplied markets but below restricted-access states. Thirty percent price compression since launch reflects normal maturation — limited by the license moratorium that prevents the wholesale collapse seen in Oregon and Michigan.

Montana achieves 107% capture at 20–23% tax — above the threshold where most states fail to achieve full displacement. Illinois at 25–35% captures 30%. The difference is that Montana's $5.34/g pre-tax is competitive with or below black market pricing in a geographically isolated state where illicit supply chains face the same transportation cost penalties that legal operators do. When pricing is neutral and retail access is saturated, the black market has no foothold.

Tax Structure

• 20% state cannabis excise tax (adult-use)
• 4% state excise tax (medical)
• 0–3% local option tax (30 counties have adopted; most at full 3%)
• Combined burden: 20–23% adult-use; 4–7% medical

The 16-percentage-point tax differential between adult-use and medical creates real economics for heavy consumers. At Montana's average pricing, the medical card break-even is approximately $900–1,000 in annual spending (~14 grams/month at $5.34/g). Consumers below that threshold are better off paying the adult-use rate. The patients who remain in the medical program — $42.7M in 2025 — are predominantly those with the strongest economic or regulatory reasons to hold a card.

Medical card costs: $20 state registration fee + $45–199/year physician consultation = $65–219/year total. A consumer spending $2,000 annually nets ~$170 after card costs; at $3,000 annual spend, ~$330.

Total Addressable Market

Montana's adult population is approximately 870,000. Applying the empirically validated consumption baseline of 18% participation at 1.0 gram per day:

• 870,000 adults 21+
• 156,600 estimated regular consumers (18%)
• 57.2 million grams annual resident demand
• Resident TAM at $5.34/g: ~$305 million

Actual 2025 combined revenue of $326.9M against the $305M resident TAM implies 107% capture. The 7% surplus comes from two sources: 13.8 million annual nonresident visitors to Glacier and Yellowstone National Parks, and cross-border demand from Wyoming, Idaho, North Dakota, and South Dakota — none of which have adult-use cannabis. Montana is the only adult-use market for hundreds of miles in every direction.

Revenue Trend

Four consecutive years of growth with decelerating rate — the signature of a market approaching steady state. The more telling story is channel migration: medical sales collapsed 59% as patients shifted to adult-use purchasing. Adult-use absorbed every dollar of that migration and grew 40% on top of it. Medical now represents 13% of total sales, down from 34% at launch. The patients who remain are economic rational actors keeping their cards for the tax differential.

Dispensary Density

Montana's 49.2 dispensaries per 100K is the highest of any state studied. The geographic distribution is shaped as much by tourism as by population.

Columbia Falls (pop. 5,829) has 13 dispensaries — 223 per 100K. Whitefish has 15 — 167 per 100K. Big Sky runs similar numbers. These aren't overbuilt relative to a population of residents; they're appropriately sized for Glacier's 3.2 million annual visitors and Yellowstone's 4.7 million. When your effective customer base is measured in annual tourists, census density figures are misleading.

Eight counties have opted out of adult-use sales under Montana's county prohibition provision. Medical-only dispensaries continue operating in those areas, and monthly sales data from opt-out counties confirms demand persists — it just flows through medical channels or drives to neighboring counties.

The License Moratorium

Montana froze new cannabis licensing at the start of adult-use sales, with only medical providers licensed before April 27, 2021 eligible to participate. SB 27, signed May 2025, extended the freeze through June 30, 2027. New applications open July 1, 2027.

This wasn't protectionism — it was a response to a market already at 49.2 dispensaries per 100K. Michigan issued unlimited licenses with no cap and produced $2.96/g wholesale collapse, mass operator losses, and a market structurally dependent on illegal exports to prohibition neighbors. Montana froze a saturated market. The $5.34/g retail price — stable compression rather than floor collapse — is the outcome. Operators remain profitable. Prices continue declining at a pace consumers and operators can both absorb.

Home Cultivation

Montana allows adults 21+ to cultivate 2 mature plants and 2 seedlings per person (4 mature + 4 seedlings per household); medical cardholders get 4 mature + 4 seedlings (8 + 8 per household). At any legal retail price, home cultivation participation runs 1–3% across every market regardless of plant limits. Montana's cultivation rights have no measurable effect on market capture in either direction.

What the CHS Literature Missed

Three Montana-connected sources address CHS — and together they bracket the argument from every direction.

The Montana Alliance of Prevention submitted an exhibit to the Montana Senate Business & Labor Committee on SB 546 in March 2023 opposing cannabis expansion. The exhibit lists CHS among short-term cannabis harms alongside overdoses and hospitalizations. No prevalence figure. An anti-legalization advocacy organization arguing before the Montana legislature against cannabis could not attach a percentage to CHS.

Montana DPHHS's Cannabis Use in Montana public health fact sheet covers driving impairment, youth use, and hospital charges — $45 million for 4,520 cannabis-related hospitalizations and ED visits in 2019. CHS is not mentioned in any state public health surveillance output.

The DEA's consumer education platform, GetSmartAboutDrugs.gov, published a July 2024 CHS awareness piece describing the condition as affecting "a small but growing number of chronic marijuana users." The federal drug enforcement agency — with maximum institutional incentive to characterize cannabis risks at their most severe — landed on "a small number" with no prevalence claim.

Montana has four years of market data, the highest per-capita dispensary density in the country, and 156,600 estimated regular consumers. Four consecutive years of volume growth with zero population-level attrition signal is consistent with what behavioral consumption analysis shows about actual CHS frequency. The DEA's "small number" framing is consistent with the data.

The Bottom Line

Montana achieved full black market displacement at a 20–23% tax burden that conventional wisdom says is too high. The mechanism isn't any single variable — it's the interaction between competitive pricing in a geographically isolated market, saturation-level retail density that leaves no consumer more than 15 minutes from a dispensary, and a license moratorium that prevented the wholesale price collapse that has destabilized oversupplied states.

The moratorium lifts in July 2027. If Montana uncaps licensing the way Michigan did, it risks trading operator stability for the $2–3/g wholesale floor that produces mass exits. If it manages the expansion carefully — prioritizing underserved areas like Great Falls at 34.5 per 100K — it can maintain competitive pricing while deepening geographic coverage. The outcome of that policy choice will be visible in the sales data by 2029.

This analysis applies the Dan K Reports Cannabis Market Framework. For methodology, assumptions, and the complete state-by-state comparison, see the framework documentation.